During this titration period, your stomach empties food at approximately 40-50% of its normal rate
You may see higher fingerprick or CGM readings, especially after meals, and possibly more variability in daily glucose levels
Swiss researchers have developed the implant so that human cells release GLP-1 when they detect caffeine
These approaches remain valuable as complements to medication but rarely achieve the magnitude of loss that pharmaceutical intervention enables
Its TRIUMPH program has now reported pivotal obesity data, with the triple agonist producing the highest Phase 3 weight loss in the class and additional readouts in diabetes, cardiovascular disease, and obesity with osteoarthritis following through 2026
The optimal approach depends on the specific peptide, target bioavailability, and tolerance for formulation complexity